Brivaracetam
N01199
Phase 3 small_molecule completed
Quick answer
Brivaracetam for Epilepsy is a Phase 3 program (small_molecule) at UCB Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UCB Pharma
- Indication
- Epilepsy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed